MetrioPharm Receives Orphan Drug Designation for the Treatment of Duchenne Muscular…
FDA grants orphan drug designation for MetrioPharm’s lead compound MP1032 for the treatment of Duchenne muscular dystrophy (DMD)DMD is a designated orphan disease in both Europe and the…